Skip to main content

Advertisement

Log in

Influence of Race on Inpatient Treatment Intensity at the End of Life

  • Original Article
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

OBJECTIVE

To examine inpatient intensive care unit (ICU) and intensive procedure use by race among Medicare decedents, using utilization among survivors for comparison.

DESIGN

Retrospective observational analysis of inpatient claims using multivariable hierarchical logistic regression.

SETTING

United States, 1989–1999.

PARTICIPANTS

Hospitalized Medicare fee-for-service decedents (n = 976,220) and survivors (n = 845,306) aged 65 years or older.

MEASUREMENTS AND MAIN RESULTS

Admission to the ICU and use of one or more intensive procedures over 12 months, and, for inpatient decedents, during the terminal admission. Black decedents with one or more hospitalization in the last 12 months of life were slightly more likely than nonblacks to be admitted to the ICU during the last 12 months (49.3% vs. 47.4%, p <.0001) and the terminal hospitalization (41.9% vs. 40.6%, p < 0.0001), but these differences disappeared or attenuated in multivariable hierarchical logistic regressions (last 12 months adjusted odds ratio (AOR) 1.0 [0.99–1.03], p = .36; terminal hospitalization AOR 1.03 [1.0–1.06], p = .01). Black decedents were more likely to undergo an intensive procedure during the last 12 months (49.6% vs. 42.8%, p < .0001) and the terminal hospitalization (37.7% vs, 31.1%, p < .0001), a difference that persisted with adjustment (last 12 months AOR 1.1 [1.08–1.14], p < .0001; terminal hospitalization AOR 1.23 [1.20–1.26], p < .0001). Patterns of differences in inpatient treatment intensity by race were reversed among survivors: blacks had lower rates of ICU admission (31.2% vs. 32.4%, p < .0001; AOR 0.93 [0.91–0.95], p < .0001) and intensive procedure use (36.6% vs. 44.2%; AOR 0.72 [0.70–0.73], p <.0001). These differences were driven by greater use by blacks of life-sustaining treatments that predominate among decedents but lesser use of cardiovascular and orthopedic procedures that predominate among survivors. A hospital’s black census was a strong predictor of inpatient end-of-life treatment intensity.

CONCLUSIONS

Black decedents were treated more intensively during hospitalization than nonblack decedents, whereas black survivors were treated less intensively. These differences are strongly associated with a hospital’s black census. The causes and consequences of these hospital-level differences in intensity deserve further study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

Similar content being viewed by others

References

  1. Smedley B, Stith A, Nelson A, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press: 2002.

  2. McBean AM, Gornick M. Differences by race in the rates of procedures performed in hospitals for Medicare beneficiaries. Health Care Financ Rev. 1994;15(4):77–90.

    PubMed  CAS  Google Scholar 

  3. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 1992;268(18):2530–6.

    Article  PubMed  CAS  Google Scholar 

  4. Ayanian JZ, Udvarhelyi IS, Gatsonis CA, Pashos CL, Epstein AM. Racial differences in the use of revascularization procedures after coronary angiography. JAMA. 1993;269(20):2642–6.

    Article  PubMed  CAS  Google Scholar 

  5. Whittle J, Conigliaro J, Good CB, Lofgren RP. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med. 1993;329(9):621–7.

    Article  PubMed  CAS  Google Scholar 

  6. Peterson ED, Wright SM, Daley J, Thibault GE. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs [see comments]. JAMA. 1994;271(15):1175–80.

    Article  PubMed  CAS  Google Scholar 

  7. Whittle J, Conigliaro J, Good CB, Joswiak M. Do patient preferences contribute to racial differences in cardiovascular procedure use? J Gen Intern Med. 1997;12(5):267–73.

    PubMed  CAS  Google Scholar 

  8. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization [see comments]. [erratum appears in N Engl J Med 1999 Apr 8;340(14):1130]. N Engl J Med. 1999;340(8):618–26.

  9. Chen J, Rathore SS, Radford MJ, Wang Y, Krumholz HM. Racial differences in the use of cardiac catheterization after acute myocardial infarction [see comments]. N Engl J Med. 2001;344(19):1443–9.

    Article  PubMed  CAS  Google Scholar 

  10. Einbinder LC, Schulman KA. The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev. 2000;57(Suppl 1):162–80.

    Article  PubMed  Google Scholar 

  11. LaVeist TA, Morgan A, Arthur M, Plantholt S, Rubinstein M. Physician referral patterns and race differences in receipt of coronary angiography. Health Serv Res. 2002;37(4):949–62.

    Article  PubMed  Google Scholar 

  12. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer [see comments]. N Engl J Med. 1999;341(16):1198–205.

    Article  PubMed  CAS  Google Scholar 

  13. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients’ preferences on racial differences in access to renal transplantation [see comments]. N Engl J Med. 1999;341(22):1661–9.

    Article  PubMed  CAS  Google Scholar 

  14. Epstein AM, Ayanian JZ, Keogh JH, et al. Racial disparities in access to renal transplantation-clinically appropriate or due to underuse or overuse? N Engl J Med. 2000;343(21):1537–44.

    Article  PubMed  CAS  Google Scholar 

  15. Pritchard RS, Fisher ES, Teno JM, et al. Influence of patient preferences and local health system characteristics on the place of death. SUPPORT Investigators. Study to understand prognoses and preferences for risks and outcomes of treatment [see comments]. J Am Geriatr Soc. 1998;46(10):1242–50.

    PubMed  CAS  Google Scholar 

  16. Greiner KA, Perera S, Ahluwalia JS. Hospice usage by minorities in the last year of life: results from the National Mortality Followback Survey. J Am Geriatr Soc. 2003;51(7):970–8.

    Article  PubMed  Google Scholar 

  17. Levinsky NG, Yu W, Ash A, et al. Influence of age on Medicare expenditures and medical care in the last year of life. JAMA. 2001;286(11):1349–55.

    Article  PubMed  CAS  Google Scholar 

  18. Hogan C, Lunney J, Gabel J, Lynn J. Medicare beneficiaries’ costs of care in the last year of life. Health Aff. 2001;20(4):188–95.

    Article  CAS  Google Scholar 

  19. Shugarman LR, Campbell DE, Bird CE, Gabel J, Louis TA, Lynn J. Differences in medicare expenditures during the last 3 years of life. J Gen Intern Med. 2004;19(2):127–35.

    Article  PubMed  Google Scholar 

  20. Garrett JM, Harris RP, Norburn JK, Patrick DL, Danis M. Life-sustaining treatments during terminal illness: who wants what? J Gen Intern Med. 1993;8(7):361–8.

    Article  PubMed  CAS  Google Scholar 

  21. O’Brien LA, Grisso JA, Maislin G, et al. Nursing home residents’ preferences for life-sustaining treatments. JAMA. 1995;274(22):1775–9.

    Article  PubMed  CAS  Google Scholar 

  22. McKinley ED, Garrett JM, Evans AT, Danis M. Differences in end-of-life decision making among black and white ambulatory cancer patients. J Gen Intern Med. 1996;11(11):651–6.

    Article  PubMed  CAS  Google Scholar 

  23. Diringer MN, Edwards DF, Aiyagari V, Hollingsworth H. Factors associated with withdrawal of mechanical ventilation in a neurology/neurosurgery intensive care unit. Crit Care Med. 2001;29(9):1792–7.

    Article  PubMed  CAS  Google Scholar 

  24. Mebane EW, Oman RF, Kroonen LT, Goldstein MK. The influence of physician race, age, and gender on physician attitudes toward advance care directives and preferences for end-of-life decision-making. J Am Geriatr Soc. 1999;47(5):579–91.

    PubMed  CAS  Google Scholar 

  25. Teno JM, Licks S, Lynn J, et al. Do advance directives provide instructions that direct care? SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatment [see comments]. J Am Geriatr Soc. 1997;45(4):508–12.

    PubMed  CAS  Google Scholar 

  26. Skinner J, Weinstein JN, Sporer SM, Wennberg JE. Racial, ethnic, and geographic disparities in rates of knee arthroplasty among Medicare patients. N Engl J Med. 2003;349(14):1350–9.

    Article  PubMed  CAS  Google Scholar 

  27. Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial disparities in acute myocardial infarction treatment and outcomes. Med Care. 2005;43(4):308–19.

    Article  PubMed  Google Scholar 

  28. Bradley EH, Herrin J, Wang Y, et al. Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA. 2004;292(13):1563–72.

    Article  PubMed  CAS  Google Scholar 

  29. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989–2000. Med Care. 2005;43(4):320–9.

    Article  PubMed  Google Scholar 

  30. Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004;351(6):575–84.

    Article  PubMed  CAS  Google Scholar 

  31. Baicker K, Chandra A, Skinner JS, Wennberg JE. Who you are and where you live: how race and geography affect the treatment of Medicare beneficiaries. Health Aff (Millwood, VA). 2004.

  32. Barnato AE, Berhane Z, Weissfeld LA, Chang CC, Linde-Zwirble WT, Angus DC. Racial variation in end-of-life intensive care use: a race or hospital effect? Health Serv Res. 2006;41(6):2219–37.

    Article  PubMed  Google Scholar 

  33. Barnato AE, McClellan MB, Kagay CR, Garber AM. Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life. Health Serv Res. 2004;39(2):363–75.

    Article  PubMed  Google Scholar 

  34. Arday SL, Arday DR, Monroe S, Zhang J. HCFA’s racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev. 2000;21(4):107–16.

    PubMed  CAS  Google Scholar 

  35. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–78.

    Article  PubMed  CAS  Google Scholar 

  36. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998;148(5):475–86.

    PubMed  CAS  Google Scholar 

  37. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.

    Article  PubMed  CAS  Google Scholar 

  38. Elixhauser A, Steiner C, Harris R, Coffey R. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.

    Article  PubMed  CAS  Google Scholar 

  39. Jha AK, Orav EJ, Li Z, Epstein AM. Where do elderly black Americans receive hospital care? Racial concentration in hospital care and the performance of hospitals that care for blacks [abstract]. J Gen Int Med. 2006;21(Suppl. 4):165.

    Google Scholar 

  40. Kleinbaum DG, Klein M. Logistic Regression, 2nd edn. New York: Springer.

  41. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.

    Article  PubMed  CAS  Google Scholar 

  42. Borum ML, Lynn J, Zhong Z. The effects of patient race on outcomes in seriously ill patients in SUPPORT: an overview of economic impact, medical intervention, and end-of-life decisions. Study to understand prognoses and preferences for outcomes and risks of treatments. J Am Geriatr Soc. 2000;48(5 Suppl):S194–8.

    PubMed  CAS  Google Scholar 

  43. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med. 1993;328(15):1092–6.

    Article  PubMed  CAS  Google Scholar 

  44. Hogan C, Lynn J, Gabel J, Lunney J, O’Mara A, Wilkinson A. (Medicare Payment Advisory Commission). Medicare Beneficiaries’ Costs and Use of Care in the Last Year of Life (MedPAC Contract Research Series). 2000 May 1, 2000. Report No.: 00–1.

  45. Ibrahim SA, Whittle J, Bean-Mayberry B, Kelley ME, Good C, Conigliaro J. Racial/ethnic variations in physician recommendations for cardiac revascularization. Am J Public Health. 2003;93(10):1689–93.

    Article  PubMed  Google Scholar 

  46. Ibrahim SA, Siminoff LA, Burant CJ, Kwoh CK. Differences in expectations of outcome mediate African American/white patient differences in “willingness” to consider joint replacement. Arthritis Rheum. 2002;46(9):2429–35.

    Article  PubMed  Google Scholar 

  47. Ibrahim SA, Siminoff LA, Burant CJ, Kwoh CK. Understanding ethnic differences in the utilization of joint replacement for osteoarthritis: the role of patient-level factors. Med Care. 2002;40(1 Suppl):I44–51.

    PubMed  Google Scholar 

  48. Shepardson LB, Gordon HS, Ibrahim SA, Harper DL, Rosenthal GE. Racial variation in the use of do-not-resuscitate orders. J Gen Intern Med. 1999;14(1):15–20.

    Article  PubMed  CAS  Google Scholar 

  49. Bach PB, Schrag D, Begg CB. Resurrecting treatment histories of dead patients: a study design that should be laid to rest. JAMA. 2004;292(22):2765–70.

    Article  PubMed  CAS  Google Scholar 

  50. Barnato AE, Lynn J. Resurrecting treatment histories of dead patients. JAMA. 2005;293(13):1591–2 (author reply 1592).

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank several anonymous reviewers for their suggestions to improve the report of our findings. An earlier version of this study, “Predictors of Intensive Inpatient Service Use Among the Elderly,” was presented in poster form at the AcademyHealth Annual Research Meeting in Nashville, TN, June, 2003.

Author contributions and data access and responsibility:

Dr. Barnato was responsible for study concept and design, analysis and interpretation of data, and preparation of the manuscript. Dr. Garber obtained the data, and was responsible for study concept and design, analysis and interpretation of data, and providing feedback on drafted manuscripts. Ms. Saynina was responsible for data analytic concept and design and for programming and providing feedback on drafted manuscripts. Dr. Chang was responsible for statistical concept and design, in addition to interpretation of the data and providing feedback on drafted manuscripts. Dr. Barnato had full access to the data while at Stanford (until July 2001); thereafter, and for the version of the analysis reported here, Olga Saynina had full access to the data. Dr. Barnato takes full responsibility for the integrity of the data and the accuracy of the data analysis.

Potential Financial Conflicts of Interest:

None of the authors has any affiliations with or financial involvement, within the past 5 years and foreseeable future (e.g., employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received, or pending royalties) with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. Disclosures: Dr. Barnato: NIH funding, no other disclosures. Dr. Chang: NIH funding, no other disclosures. Ms. Saynina: No disclosures. Dr. Garber: NIH-funding and paid and unpaid consultancies including: the Centers for Medicare and Medicaid Services’ Medicare Coverage Advisory Committee, the national Blue Cross and Blue Shield Association Medical Advisory Panel, the Institute of Medicine, the Congressional Office of Technology Assessment, and the Clinical Efficacy Assessment Project of the American College of Physicians.

Role of the sponsor:

Funding was provided by National Institute on Aging (NIA) grants AG17253 and AG050842 to Stanford University and the National Bureau of Economic Research. Dr. Barnato was supported by NIA career-development grant AG021921. The NIA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amber E. Barnato MD, MPH, MS.

Appendix

Appendix

Intensive procedures included in the study (in alphabetical order)

Amputation of lower extremity

Ankle/foot joint replacement

Aortic resection with replacement

Appendectomy

Arteriogram and venogram (not heart or head)

Automated implantable cardioverter defibrillator (AICD)

Biopsy of spinal cord

Bone marrow transplant

Cardiac assist device/ECMO/bypass

Cardiac catheterization, coronary arteriography

Carotid endarterectomy

Central vessel endarterectomy/thrombectomy

Cerebral arteriogram

Cholecystectomy and common duct exploration

Closed control of UGIB

Colon resection

Coronary artery bypass graft (CABG)

Creation of arteriovenous fistula

Cycstectomy

Electrophysiology study (EPS) +/- ablation

Enterostomy

Esophageal dilation

Esophageal reanastamosis/repair

Esophagectomy

Excision, lysis peritoneal tissue

Exploratory laparotomy

Feeding tube placement

Fundoplication

Genitourinary incontinence procedures

Hemodialysis

Hip replacement, total and partial

Hysterectomy

Ileostomy and colostomy

Injection or ligation of esophageal varices

Insert/repl/revise/remove permananent pacemaker

Insertion, temporary cardiac pacemaker

Intracoronary artery thrombolytic infusion

Intubation and Tracheostomy

Jaw fracture repair

Kidney transplant

Knee replacement

Laminectomy, diskectomy, arthrodesis

Laparoscopic cholecystectomy

Laryngectomy

Lobectomy

Local excision lung/bronchus

Mastectomy

Mastoidectomy

Mediastinoscopy

Nephrectomy

Oophorectomy, unilateral and bilateral

Open biopsy lung/bronchus

Open cholecystectomy

Open CNS biopsy

Open CNS diagnostic procedures

Open CNS therapeutic procedures

Open control of UGIB

Open heart repair of septal defects, etc.

Open or closed cardiac massage

Open Prostatectomy

Orchiectomy

Pancreatectomy/pancreaticoduodenectomy

Partial/total gastrectomy and gastric bypass

Pelvic exenteration

Percutaneous CNS biopsy (stereotactic/burr hole)

Percutaneous transluminal coronary angioplasty (PTCA)

Pericardial procedure

Peripheral vascular bypass

Peripheral vessel endarterectomy/thrombectomy

Pneumonectomy

Pyloroplasty

Radical Prostatectomy

Regional/radical lymph-node dissection

Revision/repair of vessel/vascular Procedure

Skin graft

Small bowel resection

Splenectomy

Surgical removal of urinary calculus

Thoracotomy

Thyroidectomy

Transurethral Prostatectomy (TURP)

Treatment, fracture of hip and femur

Treatment, fracture of lower extremity

Treatment, fracture of radius and ulna

Vagotomy

Valve procedures (including replacement)

Vena cava interruption

Ventricular shunt

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnato, A.E., Chang, CC.H., Saynina, O. et al. Influence of Race on Inpatient Treatment Intensity at the End of Life. J GEN INTERN MED 22, 338–345 (2007). https://doi.org/10.1007/s11606-006-0088-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11606-006-0088-x

Key words

Navigation